REVOLUTION Medicines Inc Share Price Today: Live Updates & Key Insights
REVOLUTION Medicines Inc share price today is $96.5, up -3.54%. The stock opened at $98.29 against the previous close of $99.29, with an intraday high of $98.91 and low of $94.89.
REVOLUTION Medicines Inc Share Price Chart
REVOLUTION Medicines Inc
REVOLUTION Medicines Inc Share Price Performance
REVOLUTION Medicines Inc Institutional Holdings
REVOLUTION Medicines Inc Market Status
REVOLUTION Medicines Inc Fundamentals
Market Cap 18981.05 M
PB Ratio 12.062
PE Ratio 0.0
Enterprise Value 17809.66 M
Total Assets 2354.51 M
Volume 3380707
REVOLUTION Medicines Inc Company Financials
About REVOLUTION Medicines Inc & investment objective
Company Information Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Organisation Biotechnology
Employees 883
Industry Biotechnology
CEO Dr. Mark A. Goldsmith M.D., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
REVOLUTION Medicines Inc FAQs
What is the share price of REVOLUTION Medicines Inc today?
The current share price of REVOLUTION Medicines Inc is $96.5.
Can I buy REVOLUTION Medicines Inc shares in India?
Yes, Indian investors can buy REVOLUTION Medicines Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy REVOLUTION Medicines Inc shares in India?
You can easily invest in REVOLUTION Medicines Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy REVOLUTION Medicines Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of REVOLUTION Medicines Inc.
Can I buy fractional shares of REVOLUTION Medicines Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of REVOLUTION Medicines Inc?
REVOLUTION Medicines Inc has a market cap of $18981.05 M.
In which sector does REVOLUTION Medicines Inc belong?
REVOLUTION Medicines Inc operates in the Biotechnology sector.
What documents are required to invest in REVOLUTION Medicines Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of REVOLUTION Medicines Inc?
The PE ratio of REVOLUTION Medicines Inc is N/A and the PB ratio is 12.06.